Manufacturing CA DOL H-1B OSHA ITA WARN Act

BioMarin Pharmaceutical Inc.: Full Federal Profile

BioMarin Pharmaceutical Inc. in CA (Manufacturing) shows all three federal tracks on this profile: 14 H-1B LCAs, an employer OSHA injury record, and 9 WARN notices.

Verify with OSHA → · BLS OEWS →
BioMarin Pharmaceutical Inc. workforce trust profile Three rising office-tower pillars encoding federal-records percentiles for the tracks this employer carries. BioMarin Pharmaceutical Inc. Federal records · signal DOL H-1B · OSHA ITA · WARN Act 255075100 94 signal 91 signal 1 signal Hiring Safety Stability 14 filings Grade B 9 WARN
Higher = stronger signal vs. peers (live corpus percentile 0–100 per axis present on this profile). Source: DOL OFLC, OSHA ITA, WARN Act.

BioMarin Pharmaceutical Inc. (CA): · 14 H-1B LCAs at a $193,170 disclosed median · OSHA Grade B (DART 0.66) · 9 WARN notices

According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, BioMarin Pharmaceutical Inc. in CA carries 14 H-1B wage filings on record, a $193,170 median wage (above the $120,000 national median), a solid B OSHA safety grade and 9 WARN layoff notices on file. H-1B filing volume ranks #2,023 of 36,919 sponsors in this corpus (about the 94th percentile). Every figure is a federal filing, not an estimate; see methodology for coverage limits.

  • 14 H-1B LCAs
  • $193,170 median wage
  • Grade B OSHA
  • 9 WARN

Layoff & federal record

According to U.S. Department of Labor, OSHA, and state WARN Act filings, BioMarin Pharmaceutical Inc. carries 14 H-1B wage filings on record, a $193,170 median wage (above the $120,000 national median), a solid B OSHA safety grade and 9 WARN layoff notices on file. In this corpus, H-1B filing volume ranks #2,023 of 36,919 sponsors in this corpus (about the 94th percentile), and disclosed median wage sits at the 89th percentile of 178,031 credible H-1B wage rows.

14
H-1B filings
$193,170
median H-1B wage
Grade B
OSHA safety
9
WARN notices

Figures above come from DOL H-1B LCAs, this employer's OSHA injury log, and state WARN notices, three independent disclosure systems.

DOL LCA release change

What changed between the two LCA fiscal years

FY2024 -> FY2025
  • BioMarin Pharmaceutical Inc.'s disclosed H-1B petition count rose from 5 in FY2024 to 9 in FY2025 (+80%).
  • BioMarin Pharmaceutical Inc.'s filing-count-weighted median disclosed H-1B wage rose from $139,815 in FY2024 to $183,178 in FY2025 (+31%).

Arithmetic differences between stored DOL OFLC Labor Condition Application disclosure fiscal years for this employer - not a headcount, hire forecast, or cause claim. Role mix can shift between years even when the petition total is flat.

National filing changes Two-year CSV

H-1B Filings

14

DOL labor condition applications on file

Median H-1B Salary

$193,170

Across 14 disclosed positions

OSHA Safety Grade

Grade B · DART 0.66

vs 1.14 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)

WARN Workforce Impact

373 workers

9 WARN Act notices on file

Where BioMarin Pharmaceutical Inc.'s H-1B wage sits nationally

Median disclosed wage vs. all US employers with H-1B filings

$193,170 Top 11% higher than 89% of 178,031 US employers

$0–$20,000: 1 US employers (0%). Below this entry. $20,000–$40,000: 341 US employers (0%). Below this entry. $40,000–$60,000: 5,526 US employers (3%). Below this entry. $60,000–$80,000: 16,865 US employers (9%). Below this entry. $80,000–$100,000: 30,954 US employers (17%). Below this entry. $100,000–$120,000: 33,687 US employers (19%). Below this entry. $120,000–$140,000: 28,300 US employers (16%). Below this entry. $140,000–$160,000: 21,256 US employers (12%). Below this entry. $160,000–$180,000: 14,088 US employers (8%). Below this entry. $180,000–$200,000: 9,515 US employers (5%). This entry sits in this band. $200,000–$220,000: 6,376 US employers (4%). Above this entry. $220,000–$240,000: 3,830 US employers (2%). Above this entry. $240,000–$260,000: 2,385 US employers (1%). Above this entry. $260,000–$280,000: 1,542 US employers (1%). Above this entry. $280,000–$300,000: 824 US employers (0%). Above this entry. $300,000–$320,000: 2,541 US employers (1%). Above this entry. BioMarin Pharmaceutical Inc. $0 $320,000 every US employer with H-1B filings, bucketed by value

Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026

BioMarin Pharmaceutical Inc.'s H-1B median wage, FY2024 vs FY2025

$120,000$140,000$160,000$180,000$200,000 FY2024FY2025 $139,815 $183,178 ▲ +31.0%

Filing-count-weighted median across this employer's own disclosed H-1B positions (+31% year over year), not a company-wide raise, and not adjusted for role mix changes between years.

Government Data Summary

Field Value Source
Employer Name BioMarin Pharmaceutical Inc. DOL OFLC / OSHA / WARN
Industry Manufacturing NAICS / DOL
State CA U.S. Federal Records
H-1B Filings 14 DOL OFLC LCA Disclosure
H-1B Median Salary $193,170 DOL OFLC LCA Disclosure
OSHA Safety Grade B OSHA ITA
OSHA DART Rate 0.66 OSHA ITA Establishment Records
WARN Layoff Notices 9 notice(s), 373 workers WARN Act notices, state workforce agency originals (archival backstop: LayoffData.com)

BioMarin Pharmaceutical Inc.'s values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records, WARN Act notices on file for this employer in CA (Manufacturing). In this corpus, H-1B filing volume ranks #2,023 of 36,919 sponsors in this corpus (about the 94th percentile); disclosed median wage sits at the 89th percentile of 178,031 credible H-1B wage rows; OSHA DART rate is safer than roughly 91% of 135,691 employers with an establishment injury record.

H-1B Salary Data

Job Title Median
Medical Director, Drug Safety Surveillance $252,331
Executive Director, Global Commercial Lead, Achondroplasia $235,934
VP, Head of Commercial Digital Strategy and Transformation $235,934
Director “ Global Technology Transfer $204,859
Associate Director, Sales Analytics $202,978
Associate Director, Information Technology $200,304
Director, Molecular Engineering $193,170
Manager, ERP Systems $186,035
Associate Director, Site Technical Lead $156,270
Sr. Solutions Engineer $133,952
Supervisor, QC Microbiology $107,952
Sr. Research Associate 1, Tech Ops $92,000
Research Associate 2, Flow Cytometry Core $85,197
Research Associate 2 $60,757

What the Data Says About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. operating in CA within the Manufacturing sector: the company has filed 14 H-1B labor condition applications, of which 14 disclose a usable wage figure with a median of $193,170. Records here combine U.S. Department of Labor disclosures and state workforce agency filings.

On workplace safety, BioMarin Pharmaceutical Inc. posted a DART (Days Away, Restricted, Transferred) rate of 0.66 injuries per 100 full-time workers, compared with the hours-weighted average of 1.14 for the same 2-digit NAICS sector in OSHA ITA 2022–2023 filings. Our composite grade of "B" is that employer-to-sector ratio (A ≤0.5× sector · B ≤0.8× · C ≤1.2× · D ≤1.8× · else F), so a job seeker can compare a hospital chain to a warehouse or a bank to a food processor without chasing down OSHA formulas. Across all years on file, OSHA logged 20 reportable injuries at this employer.

9 WARN Act notices affecting 373 workers have been filed against BioMarin Pharmaceutical Inc. in CA. Multiple notices can mean consolidations or broader restructuring; weigh them next to this employer's pay and safety signals, and the employer's own disclosures, when judging an offer.

BioMarin Pharmaceutical Inc. is one of the rarer profiles that carries both sponsorship volume (14 H-1B LCAs) and WARN history (9 notices) in the same public record for Manufacturing in CA. Weigh those two signals separately before treating either as the whole story.

OSHA Safety Record

Grade B DART Rate: 0.66 (same-NAICS-sector avg: 1.14)
This employer DART rate (lower is safer)
Same NAICS-sector average

BioMarin Pharmaceutical Inc.'s DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Manufacturing).

Total reported injuries on file: 20.

How BioMarin Pharmaceutical Inc. compares to Manufacturing peers

BioMarin Pharmaceutical Inc.'s nearest H-1B-filing peers in Manufacturing (home state CA). Each card links to that employer's federal-records profile.

This employer

Manufacturing · CA

BioMarin Pharmaceutical Inc.

14 H-1B filings
Median H-1B
$193,170
OSHA grade
B
WARN notices
9

Manufacturing · TX

Tesla, Inc.

856 H-1B filings
Median H-1B
$159,976
OSHA grade
F
WARN notices
1

Manufacturing · CA

Intel Corporation

766 H-1B filings
Median H-1B
$140,536
OSHA grade
C
WARN notices
58

Nationwide employers with similar H-1B volume or workplace injury rate

Two federal-records peer sets for BioMarin Pharmaceutical Inc., both outside CA so the neighborhoods are not the same-industry VsCard above.

Similar OSHA DART rate

Nearest injury-rate peers outside CA (DART 0.66 here).

Peers are nearest-neighbor matches on disclosed filing counts and OSHA ITA DART rates; employers with fewer than 100 H-1B filings or fewer than 10 reported injuries are excluded from the comparison corpus.

WARN Act Layoff History

Notice Date Workers
2024-09-03 94
2024-09-03 52
2024-09-03 1
2024-05-14 57
2024-05-14 71
2024-05-14 3
2024-05-14 1
2022-10-10 62
2022-10-10 32

What to check before working with BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. needs a three-way read: H-1B pay (14 LCAs), safety (grade B), and WARN history (9 notices); none of those alone is the rating.

  • H-1B median is $193,170 across 14 disclosed-wage positions (of 14 total filings), benchmark any offer against it and the metro prevailing wage. Compare with peers
  • Safety grade B reflects a DART rate read against the Manufacturing average of 1.14 - a relative benchmark, not an absolute verdict. How grades work
  • 9 WARN layoff notices on file, review the timing before counting on job stability. Reading WARN notices

BioMarin Pharmaceutical Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.

Read with this employer

Retrieved and formatted by PlainEmployers.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.

Learn more: Safety Grades Explained | H-1B Salary Negotiation

This profile is rendered directly from DOL H-1B disclosure filings, OSHA Injury Tracking Application records and state WARN Act layoff notices, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.